Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial
JM Coutinho, JM Ferro, SM Zuurbier… - … journal of stroke, 2013 - journals.sagepub.com
Rationale Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO‐ACT trial
JM Coutinho, JM Ferro, SM Zuurbier, MS Mink… - International Journal of …, 2013 - infona.pl
Rationale Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis: Rationale and Design of the TO-ACT Trial
JM Coutinho, JM Ferro, SM Zuurbier, MS Mink… - International Journal of …, 2012 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Rationale</jats: title>< jats: p> Endovascular thrombolysis, with
or without mechanical clot removal, may be beneficial for a subgroup of patients with …
or without mechanical clot removal, may be beneficial for a subgroup of patients with …
[PDF][PDF] Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial
JM Coutinho, JM Ferro, SM Zuurbier, MS Mink… - 2011 - researchgate.net
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the
TOACT trial Page 1 Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale …
TOACT trial Page 1 Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale …
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO‐ACT trial
JM Coutinho, JM Ferro, SM Zuurbier… - … Journal of Stroke, 2013 - Wiley Online Library
Rationale Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
[PDF][PDF] Thrombolysis Or Anticoagulation for Cerebral venous Thrombosis: rationale and design of the TO-ACT trial
JM Coutinho, JM Ferro, SM Zuurbier, M Mink… - … and treatment of …, 2013 - pure.uva.nl
Rationale Endovascular thrombolysis, with or without mechanical clot removal (ET), may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT), who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT), who have …
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.
JM Coutinho, JM Ferro, SM Zuurbier… - … Journal of Stroke, 2013 - search.ebscohost.com
Rationale Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial
JM Coutinho, JM Ferro… - International …, 2013 - researchinformation.amsterdamumc …
Endovascular thrombolysis, with or without mechanical clot removal, may be beneficial for a
subgroup of patients with cerebral venous sinus thrombosis (CVT) who have a poor …
subgroup of patients with cerebral venous sinus thrombosis (CVT) who have a poor …
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.
JM Coutinho, JM Ferro, SM Zuurbier… - … Journal of Stroke …, 2012 - europepmc.org
RATIONALE: Endovascular thrombolysis, with or without mechanical clot removal, may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT) who have …
[PDF][PDF] Thrombolysis Or Anticoagulation for Cerebral venous Thrombosis: rationale and design of the TO-ACT trial
JM Coutinho, JM Ferro, SM Zuurbier, M Mink… - … and treatment of …, 2013 - dare.uva.nl
Rationale Endovascular thrombolysis, with or without mechanical clot removal (ET), may be
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT), who have …
beneficial for a subgroup of patients with cerebral venous sinus thrombosis (CVT), who have …